Enliven Therapeutics ELVN Delivers Q1 2026 Beat EPS 038 vs 047 Expected Amgen Price Target Reduced at Piper Sandler but LongTerm Outlook Remains Positive Fifth FITBP Q1 2026 Earnings Beat Revenue NA EPS 084 American Res AREC Q3 2025 Earnings 007 EPS Surges Past 011 Estimates